Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)

ClinicalTrials.gov ID: NCT00543400

Public ClinicalTrials.gov record NCT00543400. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 8:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective is to evaluate the safety and feasibility of using M118 as an anticoagulant in the target population of subjects with stable coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI). The secondary objectives are to evaluate the effect of M118 on procedural indices including procedure success, abrupt closure, post-procedure TIMI flow, and catheter thrombus. Substudy Primary Objective The primary objective of the substudy is to characterize the pharmacokinetic and pharmacodynamic profile of M118 among subjects with stable coronary artery disease undergoing elective PCI.

Study identification

NCT ID
NCT00543400
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Momenta Pharmaceuticals, Inc.
Industry
Enrollment
503 participants

Conditions and interventions

Eligibility (public fields only)

Age range
19 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2007 (Type not available)
Primary completion
Apr 2009 (Actual)
Completion
May 2009 (Actual)
Last update posted
Oct 15, 2019

2007 – 2009

United States locations

U.S. sites
37
U.S. states
19
U.S. cities
36
Facility City State ZIP Site status
Central Arkansas Veterans Healthcare System Little Rock Arkansas 72205 —
Washington Hospital Center, Medstar Research Institute Washington D.C. District of Columbia 20010 —
Jim Moran Heart & Vascular Research Institute Fort Lauderdale Florida 33308 —
Shands Jacksonville Medical Center (UFL) Jacksonville Florida 32209 —
Cardiology Research Associates Ormond Beach Florida 32174 —
Suncoast Cardiovascular Research St. Petersburg Florida 33701 —
Emory University Hospital Atlanta Georgia 30322 —
Advocate Good Shephard Hospital Barrington Illinois 60010 —
Rush University Medical Center Chicago Illinois 60612 —
University of Chicago Chicago Illinois 60637 —
Trinity Medical Center Rock Island Illinois 61201 —
Midwest Cardiovascular Research Foundation Davenport Iowa 52803 —
University of Kentucky-Gill Heart Institute Lexington Kentucky 40536 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
University of Michigan Health System Ann Arbor Michigan 48109-5869 —
Henry Ford Hospital Heart & Vascular Institute Detroit Michigan 48202 —
Genesys Regional Medical Center Grand Blanc Michigan 48439 —
Saint Mary's Duluth Clinic Health Center Duluth Minnesota 55805 —
Minneapolis VA Medical Center Minneapolis Minnesota 55417 —
Saint-Luke's Hospital / Mid America Heart Institute Kansas City Missouri 64111 —
Saint Louis University Hospital St Louis Missouri 63110 —
UNC Health Systems Chapel Hill North Carolina 27514 —
Wake Forest University Health Sciences Winston-Salem North Carolina 27157-1045 —
Riverside Methodist Hospital Columbus Ohio 43214 —
Genesis Health Care System Zanesville Ohio 43701 —
Allegheny Hospital Pittsburgh Pennsylvania 15212 —
Black Hills Clinical Research Center Rapid City South Dakota 57701 —
Centennial Heart Cardiovascular Consultants Nashville Tennessee 37203 —
Northwest Texas Healthcare System_Amarillo Heart Clinical Research Institute, Inc. Amarillo Texas 79106 —
Austin Heart, P.A. Austin Texas 78756 —
Plaza Medical Center of Fort Worth Fort Worth Texas 76104 —
The Methodist Hospital Houston Texas 77030 —
Victoria Heart & Vascular Center Victoria Texas 77901 —
Providence Health Center Waco Texas 76712 —
UVA Cardiology, UVA Health System Charlottesville Virginia 22908 —
McGuire VA Medical Center Richmond Virginia 23249 —
Comprehensive Cardiology Care Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00543400, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 15, 2019 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00543400 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →